Moderna(MRNA) - 2025 Q4 - Annual Results

Revenue Expectations - Moderna expects approximately $1.9 billion in revenue for the fiscal year ended December 31, 2025[4] Operating Expenses - The company anticipates GAAP operating expenses of $5.0 - $5.2 billion for the fiscal year ended December 31, 2025[4] Financial Position - Moderna's expected cash, cash equivalents, and investments in marketable securities as of December 31, 2025, is approximately $8.1 billion[4]